These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 39158668)
1. Optimizing the spatial immune landscape of CD103 Yang G; Hu M; Cai S; Li C; Yang L; Zhao M; Jing H; Xing L; Sun X Cell Oncol (Dordr); 2024 Oct; 47(5):1957-1971. PubMed ID: 39158668 [TBL] [Abstract][Full Text] [Related]
2. Spatial features of specific CD103 Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111 [TBL] [Abstract][Full Text] [Related]
4. Functional Heterogeneity of CD4 Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P Front Immunol; 2018; 9():2654. PubMed ID: 30505306 [TBL] [Abstract][Full Text] [Related]
5. The Emerging Role of CD8 Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F Front Immunol; 2018; 9():1904. PubMed ID: 30158938 [TBL] [Abstract][Full Text] [Related]
6. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients. Cai S; Zhao M; Yang G; Li C; Hu M; Yang L; Xing L; Sun X Int Immunopharmacol; 2024 Aug; 137():112434. PubMed ID: 38889507 [TBL] [Abstract][Full Text] [Related]
7. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13 Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519 [TBL] [Abstract][Full Text] [Related]
8. Higher frequency of peripheral blood CD103 Liu L; Lai W; Zhuo X; Chen S; Luo X; Tan H Front Immunol; 2024; 15():1437726. PubMed ID: 39391310 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive meta-analysis of tissue resident memory T cells and their roles in shaping immune microenvironment and patient prognosis in non-small cell lung cancer. Shen A; Garrett A; Chao CC; Liu D; Cheng C; Wang Z; Qian C; Zhu Y; Mai J; Jiang C Front Immunol; 2024; 15():1416751. PubMed ID: 39040095 [TBL] [Abstract][Full Text] [Related]
10. The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach. Min J; Dong F; Chen Y; Li W; Wu Y; Tan Y; Yang F; Wu P; Chai Y Front Immunol; 2024; 15():1379812. PubMed ID: 39315096 [TBL] [Abstract][Full Text] [Related]
11. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111 [TBL] [Abstract][Full Text] [Related]
12. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma. Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027 [TBL] [Abstract][Full Text] [Related]
13. CD8 Mauro D; Lin X; Pontarini E; Wehr P; Guggino G; Tang Y; Deng C; Gandolfo S; Xiao F; Rui K; Huang E; Tian J; Raimondo S; Rischmueller M; Boroky J; Downie-Doyle S; Nel H; Baz-Morelli A; Hsu A; Maraskovsky E; Barr A; Hemon P; Chatzis L; Boschetti CE; Colella G; Alessandro R; Rizzo A; Pers JO; Bombardieri M; Thomas R; Lu L; Ciccia F Ann Rheum Dis; 2024 Sep; 83(10):1345-1357. PubMed ID: 38777379 [TBL] [Abstract][Full Text] [Related]
15. CD28/PD1 co-expression: dual impact on CD8 Palermo B; Franzese O; Frisullo G; D'Ambrosio L; Panetta M; Campo G; D'Andrea D; Sperduti I; De Nicola F; Goeman F; Gallina F; Visca P; Facciolo F; Nisticò P J Exp Clin Cancer Res; 2023 Oct; 42(1):287. PubMed ID: 37898752 [TBL] [Abstract][Full Text] [Related]
16. Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC. Chen Y; Shao Z; Hao Z; Xin Z; Chen X; Huang L; Chen D; Lin M; Liu Q; Xu X; Li J; Wu D; Yan J; Chai Y; Wu P J Immunother Cancer; 2024 Aug; 12(8):. PubMed ID: 39134346 [TBL] [Abstract][Full Text] [Related]
17. Characterization of CD103 Han L; Gao QL; Zhou XM; Shi C; Chen GY; Song YP; Yao YJ; Zhao YM; Wen XY; Liu SL; Qi YM; Gao YF Cancer Immunol Immunother; 2020 Aug; 69(8):1493-1504. PubMed ID: 32285170 [TBL] [Abstract][Full Text] [Related]
18. Peripheral CD8 Guo W; Qiao T; Li H; Zhao Y; Qin J; Zhang C; Shi C Cancer Lett; 2024 Aug; 597():217073. PubMed ID: 38906523 [TBL] [Abstract][Full Text] [Related]
19. Fatty Acid Oxidation Controls CD8 Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801 [TBL] [Abstract][Full Text] [Related]
20. Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD). Zeng A; Yin Y; Xu Z; Abuduwayiti A; Yang F; Shaik MS; Wang C; Chen K; Wang C; Fang X; Dai J BMC Cancer; 2024 Mar; 24(1):396. PubMed ID: 38553708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]